Publication | Closed Access
Clinical trial: a controlled trial of baclofen add‐on therapy in <scp>PPI</scp> ‐refractory gastro‐oesophageal reflux symptoms
16
Citations
23
References
2022
Year
Baclofen decreases several reflux parameters in PPI refractory GERD symptoms, but pH-impedance monitoring is necessary before treatment as only SAP+ patients experience clinical benefit after 4 weeks.
| Year | Citations | |
|---|---|---|
Page 1
Page 1